Breaking
The initial portfolio comprises more than 20 products across sterile injectables, biologics and topical formulations, which will be manufactured at Aurigene’s facilities in India.
Read full story on The Hindu →
India — The Hindu
The initial portfolio comprises more than 20 products across sterile injectables, biologics and topical formulations, which will be manufactured at Aurigene’s facilities in India.
This report is published with credit to The Hindu. The wire sent a summary; open the original for any extra context. Read on The Hindu →
Source: The Hindu. Published 25 Aug 2026, 01:37 pm.
Most relevant
Spot gold touches almost $4,700 an ounce and Bitcoin tops $80,000 while oil prices fall despite threat of heavy US sanctions on Iran and any country trading with it
Read on theguardian.com →